Skip to main content
. 2021 Oct 6;18(11):4079–4089. doi: 10.1021/acs.molpharmaceut.1c00480

Figure 3.

Figure 3

Dissolution profiles of amorphous formulations of (a) FDN (green) and (b) IPM (blue). Formulations contained 80% HPMCAS and 20% drug(s) in FaSSIF. Circles (◯) represent FDN or IPM alone and triangles (△) a 1:1 M ratio of FDN and IPM. Error bars (three replicates) show standard deviations (error bars are smaller than the symbols for some measurements).